Genetic Tools and Technologies Related News

UKI2S announces seed investment in Cagen, a pioneering synthetic biology company using protein nanocages

UK Innovation & Science Seed Fund (UKI2S) and Imperial Innovations announce the launch of Cagen, a company focused on innovative uses of protein nanocages. Founded by Dr Geoff Baldwin, Reader in Biochemistry at Imperial College London, Cagen has developed [...]

Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines

7th August 2018, Oxford – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has secured a multi-million pound contract with a leading multi-billion dollar global ecommerce provider of reagents and tools to the [...]

Calyxt and S&W Seed Company Announce Milestone in Alfalfa Seed Development Program

MINNEAPOLIS & ST. PAUL, Minn. & SACRAMENTO, Calif – July 19, 2018 – Calyxt, Inc. (Nasdaq: CLXT), a consumer-centric, food- and agriculture-focused company, and S&W Seed Company (Nasdaq: SANW), a global leader in the alfalfa seed industry, today announced the successful [...]

Re-introducing CRISPR: The Google Search of the genome

This story is brought to you by Mammoth Biosciences, whose researchers are building a CRISPR-based platform for an endless variety of tests for bio sensing in healthcare, agriculture, manufacturing, forensics, and more. Learn more at While CRISPR continues to [...]

Codexis Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development

REDWOOD CITY, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Hicham Alaoui, Ph.D. to the newly created position of Vice President, Biotherapeutics Research & Development. The appointment brings Dr. [...]

Inscripta Granted Patents for CRISPR Gene-Editing Systems

New data shows Inscripta’s MADzymes edit in mammalian cells Boulder, Colo. – July 12, 2018 – Inscripta, a leading gene-editing technology company, today announced two significant milestones. First, the USPTO granted Inscripta its first patent covering systems using MAD7, [...]